• 1
    Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 213750.
  • 2
    American Cancer Society. Cancer facts & figures 2007. Oakland, CA: American Cancer Society, 2007.
  • 3
    Blot WJ,McLaughlin JK,Winn DM,Austin DF,Greenberg RS,Preston-Martin S,Bernstein L,Schoenberg JB,Stemhagen A,Fraumeni JF,Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 32827.
  • 4
    Schottenfeld D,Fraumeni JF. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006.
  • 5
    Kubota Y,Nash RA,Klungland A,Schar P,Barnes DE,Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 1996; 15: 666270.
  • 6
    Masson M,Niedergang C,Schreiber V,Muller S,Menissier-de Murcia J,de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998; 18: 356371.
  • 7
    Lunn RM,Langlois RG,Hsieh LL,Thompson CL,Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999; 59: 255761.
  • 8
    Matullo G,Palli D,Peluso M,Guarrera S,Carturan S,Celentano E,Krogh V,Munnia A,Tumino R,Polidoro S,Piazza A,Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22: 143745.
  • 9
    Duell EJ,Wiencke JK,Cheng TJ,Varkonyi A,Zuo ZF,Ashok TD,Mark EJ,Wain JC,Christiani DC,Kelsey KT. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 96571.
  • 10
    Lei YC,Hwang SJ,Chang CC,Kuo HW,Luo JC,Chang MJ,Cheng TJ. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 2002; 519: 93101.
  • 11
    Abdel-Rahman SZ,El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 2000; 159: 6371.
  • 12
    Pastorelli R,Cerri A,Mezzetti M,Consonni E,Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int J Cancer 2002; 100: 913.
  • 13
    Hsieh LL,Chien HT,Chen IH,Liao CT,Wang HM,Jung SM,Wang PF,Chang JT,Chen MC,Cheng AJ. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 2003; 12: 43943.
  • 14
    Tuimala J,Szekely G,Gundy S,Hirvonen A,Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002; 23: 10038.
  • 15
    Tae K,Lee HS,Park BJ,Park CW,Kim KR,Cho HY,Kim LH,Park BL,Shin HD. Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 2004; 111: 8058.
  • 16
    Demokan S,Demir D,Suoglu Y,Kiyak E,Akar U,Dalay N. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol Oncol Res 2005; 11: 225.
  • 17
    Ramachandran S,Ramadas K,Hariharan R,Rejnish Kumar R,Radhakrishna Pillai M. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 2006; 42: 35062.
  • 18
    Olshan AF,Watson MA,Weissler MC,Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002; 178: 1816.
  • 19
    Majumder M,Sikdar N,Paul RR,Roy B. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci. GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol Biomarkers Prev 2005; 14: 210612.
  • 20
    Zhang X,Morera S,Bates PA,Whitehead PC,Coffer AI,Hainbucher K,Nash RA,Sternberg MJ,Lindahl T,Freemont PS. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J 1998; 17: 640411.
  • 21
    Huang WY,Olshan AF,Schwartz SM,Berndt SI,Chen C,Llaca V,Chanock SJ,Fraumeni JF,Jr.,Hayes RB. Selected genetic polymorphisms in MGMT. XRCC1, XPD, and. XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 174753.
  • 22
    Sturgis EM,Castillo EJ,Li L,Zheng R,Eicher SA,Clayman GL,Strom SS,Spitz MR,Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999; 20: 21259.
  • 23
    Li C,Hu Z,Lu J,Liu Z,Wang LE,El-Naggar AK,Sturgis EM,Spitz MR,Wei Q. Genetic polymorphisms in DNA base-excision repair genes ADPRT. XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 2007; 110: 86775.
  • 24
    Haraf DJ,Nodzenski E,Brachman D,Mick R,Montag A,Graves D,Vokes EE,Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996; 2: 75562.
  • 25
    Gillison ML,Koch WM,Capone RB,Spafford M,Westra WH,Wu L,Zahurak ML,Daniel RW,Viglione M,Symer DE,Shah KV,Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 70920.
  • 26
    Schwartz SR,Yueh B,McDougall JK,Daling JR,Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001; 125: 19.
  • 27
    Ritchie JM,Smith EM,Summersgill KF,Hoffman HT,Wang D,Klussmann JP,Turek LP,Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 33644.
  • 28
    Ringstrom E,Peters E,Hasegawa M,Posner M,Liu M,Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 318792.
  • 29
    Portugal LG,Goldenberg JD,Wenig BL,Ferrer KT,Nodzenski E,Sabnani JB,Javier C,Weichselbaum RR,Vokes EE. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123: 12304.
  • 30
    Sisk EA,Soltys SG,Zhu S,Fisher SG,Carey TE,Bradford CR. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 2002; 24: 8419.
  • 31
    Chiba I,Shindoh M,Yasuda M,Yamazaki Y,Amemiya A,Sato Y,Fujinaga K,Notani K,Fukuda H. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996; 12: 16638.
  • 32
    Applebaum KM,Furniss CS,Zeka A,Posner MR,Smith JF,Bryan J,Eisen EA,Peters ES,McClean MD,Kelsey KT. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99: 180110.
  • 33
    Peters ES,Luckett BG,Applebaum KM,Marsit CJ,McClean MD,Kelsey KT. Dairy products, leanness, and head and neck squamous cell carcinoma. Head Neck 2008; 30: 1193205.
  • 34
    Meyer MS,Applebaum KM,Furniss CS,Peters ES,Luckett BG,Smith JF,Bryan J,McClean MD,Marsit C,Kelsey KT. Human papillomavirus 16 modifies the association between fruit consumption and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 341926.
  • 35
    Furniss CS,McClean MD,Smith JF,Bryan J,Nelson HH,Peters ES,Posner MR,Clark JR,Eisen EA,Kelsey KT. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007; 120: 238692.
  • 36
    Dias D,Van Doren J,Schlottmann S,Kelly S,Puchalski D,Ruiz W,Boerckel P,Kessler J,Antonello JM,Green T,Brown M,Smith J, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 2005; 12: 95969.
  • 37
    Rothman KJ,Greenland S. Modern epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
  • 38
    Kraft P,Yen YC,Stram DO,Morrison J,Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered 2007; 63: 1119.
  • 39
    Zaykin DV,Westfall PH,Young SS,Karnoub MA,Wagner MJ,Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 7991.
  • 40
    Kraft P,Cox DG,Paynter RA,Hunter D,De Vivo I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005; 28: 26172.
  • 41
    Rapp L,Chen JJ. The papillomavirus E6 proteins. Biochim Biophys Acta 1998; 1378: F1F19.
  • 42
    Munger K,Werness BA,Dyson N,Phelps WC,Harlow E,Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989; 8: 4099105.
  • 43
    Boyle JO,Hakim J,Koch W,van der Riet P,Hruban RH,Roa RA,Correo R,Eby YJ,Ruppert JM,Sidransky D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 447780.
  • 44
    Brennan JA,Boyle JO,Koch WM,Goodman SN,Hruban RH,Eby YJ,Couch MJ,Forastiere AA,Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 7127.
  • 45
    Nelson HH,Kelsey KT,Mott LA,Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 2002; 62: 1525.
  • 46
    Kelsey KT,Park S,Nelson HH,Karagas MR. A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 133741.
  • 47
    Han J,Hankinson SE,Colditz GA,Hunter DJ. Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br J Cancer 2004; 91: 16049.
  • 48
    Majumder M,Sikdar N,Ghosh S,Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 2007; 120: 214856.
  • 49
    Mathonnet G,Labuda D,Meloche C,Wambach T,Krajinovic M,Sinnett D. Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes. J Hum Genet 2003; 48: 65964.
  • 50
    Duell EJ,Holly EA,Bracci PM,Wiencke JK,Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 2002; 62: 46306.
  • 51
    Iftner T,Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003: 808.
  • 52
    Newall AT,Brotherton JM,Quinn HE,McIntyre PB,Backhouse J,Gilbert L,Esser MT,Erick J,Bryan J,Formica N,MacIntyre CR. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis 2008; 46: 164755.
  • 53
    Persson PG,Norell SE. Retrospective versus original information on cigarette smoking. Implications for epidemiologic studies. Am J Epidemiol 1989; 130: 70512.